VMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Viemed Healthcare Inc (VMD) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown strong financial growth in the latest quarter, the lack of positive trading signals, insider selling, and neutral technical indicators suggest that this is not an optimal entry point. The investor may consider monitoring the stock for better opportunities.
The technical indicators are mixed. The MACD is negatively expanding below zero, suggesting bearish momentum. RSI is neutral at 49.376, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 9.53, R1: 9.889, S1: 9.171, R2: 10.111, S2: 8.95. The pre-market price is $9.67, slightly above the pivot level, indicating minor bullish sentiment.
Strong financial performance in 2025/Q4, with revenue up 25.51% YoY, net income up 30.65% YoY, and EPS up 40.00% YoY.
Insiders are selling, with a 207.27% increase in selling activity over the last month. No recent news or congress trading data to support a positive sentiment. The MACD indicates bearish momentum, and the stock has a 50% chance of declining in the next week.
In 2025/Q4, revenue increased to $76,181,000 (up 25.51% YoY), net income increased to $5,639,000 (up 30.65% YoY), and EPS increased to 0.14 (up 40.00% YoY). However, gross margin dropped to 57.38%, down -2.71% YoY.
No recent analyst rating or price target changes are available for evaluation.
